• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Emergency

Risk factors for SARS-CoV-2 seropositivity in health care workers

byThomas SuandHarsh Shah
February 10, 2021
in Emergency, Infectious Disease, Public Health
Reading Time: 2 mins read
Share on FacebookShare on Twitter

1. Residence in a community with coronavirus disease 2019 (COVID-19) incidence, direct community contact with a positive case, and Black race were associated with a greater risk of infection.

2. No statistically significant difference was observed with regard to any occupational risk factors in the base case analysis.

Evidence Rating Level: 2 (Good)

Study Rundown: While occupational exposure to infected patients and colleagues is commonly believed to be a driving force behind severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence in health care workers (HCWs), little concrete evidence exists regarding the relative contributions of workplace versus community risk factors toward infection rates. This study involving the Emory healthcare system aimed to clarify the roles of occupational, community, and demographic risk factors. After sampling over one-third of the entire workforce, the study found that community exposure and race were most strongly associated with seropositivity. Health care workers working in clinical locations had numerically greater odds of being infected. Further, HCWs who identified as Black were more than 2 times as likely to be seropositive than those who identified as White. Like its predecessors, this study was limited by participation bias as well as the challenges in classifying personnel who may have worked in multiple roles and locations or were confronted with rapidly changing infection control guidelines. Nonetheless, these findings may aid in the optimization of strategies to continue protecting HCWs in the ongoing pandemic.

Click here to read the study in Annals of Internal Medicine

Relevant Reading: Prevalence of SARS-CoV-2 antibodies in health care personnel in the New York City area

RELATED REPORTS

Male sex and hispanic ethnicity are associated with increased risk of early-onset colorectal cancer

Ensitrelvir associated with reduced risk of Covid-19 among household contacts

Social determinants of health associated with development of long COVID

In-Depth [cross-sectional study]: Of the approximately 30,000 employees and staff in the Emory healthcare system, 10,275 (35%) participated in voluntary serological testing from 19 April through 26 June 2020 at seven centers throughout the Atlanta, GA metropolitan area. The enzyme-linked immunosorbent assay had an estimated sensitivity of 97.5% and specificity of 98.0%. Demographic information and data regarding the use of personal protective equipment and potential exposures were also collected. Less than one-quarter of participants were male, and less than one-third were Black despite comprising nearly half of the workforce. Among all participants, the adjusted seroprevalence was 3.8% (95% confidence interval [95% CI], 3.4% to 4.3%). Race (adjusted odds ratio [aOR] for Black vs. White, 2.1; 95% CI, 1.7 to 2.6), contact with a person known or suspected to have COVID-19 outside the workplace (aOR, 1.9; CI,1.4 to 2.6), and higher residential ZIP code incidence of COVID-19 (aOR, 1.5; CI, 1.0 to 2.2) were most strongly associated with seropositivity. A number of occupational risk factors were also numerically related to seropositivity, including close contact with a COVID-19–positive HCW (aOR, 1.2; CI, 0.9 to 1.6) and working in clinical locations such as the emergency department (aOR, 1.5; CI, 0.9 to 2.7), inpatient non–COVID-19–focused areas (aOR, 1.4; CI, 0.8 to 2.3), or COVID-19–focused units (aOR, 1.6; CI, 0.9 to 2.7). However, workplace role did not appear to be correlated with seropositivity after adjusting for demographic factors (aOR for respiratory therapists, 0.9; CI, 0.3 to 2.5).

Image: PD 

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: healthcare workersrisk factorsSARS-CoV-2
Previous Post

#VisualAbstract: Endocrine therapy plus oral S-1 improves invasive disease-free survival in patients with ER⁺ breast cancer

Next Post

Tirbanibulin ointment potentially effective for actinic keratosis treatment

RelatedReports

Quick Take: Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening
Chronic Disease

Male sex and hispanic ethnicity are associated with increased risk of early-onset colorectal cancer

June 29, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Infectious Disease

Ensitrelvir associated with reduced risk of Covid-19 among household contacts

May 26, 2026
Galcanezumab reduces the frequency of episodic cluster headaches
Public Health

Social determinants of health associated with development of long COVID

August 3, 2025
Being overweight and obese associated with increased incidence of chronic kidney disease
Chronic Disease

Worsening kidney function observed following SARS-CoV-2 infection in children

May 23, 2025
Next Post
Video-based behavioral intervention benefits clinical skin examinations

Tirbanibulin ointment potentially effective for actinic keratosis treatment

Compliance-linked incentives increase infant immunizations rates in rural India

Adenovirus encoding hepatitis C virus vaccine is safe but effectiveness is unclear

Quick Take: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial

Nivolumab plus ipilimumab increases overall survival in patients with malignant pleural mesothelioma

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar
  • Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma
  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.